CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+3.81%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$119M
AUM Growth
+$119M
(-4.3%)
Cap. Flow
-$6.38M
Cap. Flow
% of AUM
-5.36%
Top 10 Holdings %
Top 10 Hldgs %
36.72%
Holding
80
New
8
Increased
27
Reduced
7
Closed
11
Top Buys
| 1 |
Incyte
INCY
|
$1.71M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$1.63M |
| 3 |
Baidu
BIDU
|
$1.58M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$1.51M |
| 5 |
Alibaba
BABA
|
$1.45M |
Top Sells
| 1 |
IMGN
Immunogen Inc
IMGN
|
$14.8M |
| 2 |
National Healthcare
NHC
|
$2.77M |
| 3 |
TAST
Carrols Restaurant Group, Inc.
TAST
|
$2.76M |
| 4 |
Freeport-McMoran
FCX
|
$2.13M |
| 5 |
BGC Group
BGC
|
$1.94M |
Sector Composition
| 1 | Healthcare | 42.71% |
| 2 | Industrials | 9.53% |
| 3 | Technology | 8.54% |
| 4 | Materials | 8.18% |
| 5 | Consumer Staples | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Talos Energy
TALO
$1.74B
| $1.74M | 1.46% |
125,000
+55,000
| +79% | +$766K |
|
|
27
Incyte
INCY
$16.8B
| $1.71M | 1.44% |
+30,000
| New | +$1.71M |
|
|
28
Baidu
BIDU
$33.1B
| $1.58M | 1.33% |
+15,000
| New | +$1.58M |
|
29
First Horizon
FHN
$11.5B
| $1.54M | 1.29% |
100,000
+50,000
| +100% | +$770K |
|
30
Republic Bancorp
RBCAA
$1.5B
| $1.53M | 1.29% |
30,000
+2,500
| +9% | +$128K |
|
31
Pan American Silver
PAAS
$12.4B
| $1.51M | 1.27% |
100,000
| – | – |
|
|
32
Jazz Pharmaceuticals
JAZZ
$7.75B
| $1.51M | 1.26% |
+12,500
| New | +$1.51M |
|
|
CGAU
33
Centerra Gold
CGAU
$1.72B
| $1.48M | 1.24% |
250,000
+100,000
| +67% | +$591K |
|
34
AMCON Distributing
DIT
$77.4M
| $1.47M | 1.24% |
8,000
| – | – |
|
|
35
Alibaba
BABA
$330B
| $1.45M | 1.22% |
+20,000
| New | +$1.45M |
|
36
Newell Brands
NWL
$2.45B
| $1.41M | 1.18% |
175,000
| – | – |
|
37
Pfizer
PFE
$142B
| $1.39M | 1.17% |
50,000
| – | – |
|
|
B
38
Barrick Mining Corporation
B
$45.9B
| $1.33M | 1.12% |
80,000
+30,000
| +60% | +$499K |
|
39
Xoma
XOMA
$392M
| $1.32M | 1.11% |
55,000
| – | – |
|
40
Curis
CRIS
$20.9M
| $1.3M | 1.1% |
120,000
+95,000
| +380% | +$1.03M |
|
|
RVNC
41
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.23M | 1.03% |
250,000
+175,000
| +233% | +$861K |
|
42
Sabre
SABR
$690M
| $1.21M | 1.02% |
500,000
+200,000
| +67% | +$484K |
|
43
Atea Pharmaceuticals
AVIR
$267M
| $1.09M | 0.92% |
270,000
| – | – |
|
44
Coya Therapeutics
COYA
$110M
| $992K | 0.83% |
100,000
| – | – |
|
45
Nektar Therapeutics
NKTR
$553M
| $878K | 0.74% |
939,847
| – | – |
|
46
Park Hotels & Resorts
PK
$2.32B
| $875K | 0.73% |
50,000
-10,000
| -17% | -$175K |
|
47
Heron Therapeutics
HRTX
$202M
| $831K | 0.7% |
300,000
-25,000
| -8% | -$69.3K |
|
48
Cytosorbents Corp
CTSO
$59.2M
| $784K | 0.66% |
825,000
+410,000
| +99% | +$390K |
|
49
Acadia Pharmaceuticals
ACAD
$4.38B
| $740K | 0.62% |
40,000
+10,000
| +33% | +$185K |
|
50
Battalion Oil
BATL
$19.3M
| $736K | 0.62% |
130,000
+21,700
| +20% | +$123K |
|